Prof. Leyla Ağaoğlu is a pediatric hematology and oncology specialist with extensive clinical and academic experience. She graduated from Istanbul University Faculty of Medicine in 1997, completing her training in Pediatric Hematology and Oncology. Since 2007 she has been affiliated with Acibadem Health Group, where she provides care for children with hematologic and oncologic conditions and participates in multidisciplinary treatment and research programs. She is an active member of numerous national and international professional societies, including the International Society of Pediatric Oncology (SIOP), Children’s Oncology Group (COG), American Society of Pediatric Hematology/Oncology (ASPHO), American Society of Clinical Oncology (ASCO), European Hematology Association (EHA), and International Society of Hematology (ISH). National memberships include the Turkish Pediatric Association, Turkish Medical Association, National Pediatric Institute, Turkish Pediatric Oncology Group (TPOG), Turkish Pediatric Hematology Society (TPHD), and Turkish Hematology Association (THD). Dr. Ağaoğlu is committed to delivering evidence-based, compassionate care to pediatric patients, advancing pediatric oncology through collaboration, and contributing to education and research in pediatric hematology-oncology.
Education
- 1997 Istanbul University Istanbul Faculty of Medicine Pediatric Hematology and Oncology
- 1988 Istanbul University Istanbul Faculty of Medicine, Pediatrics / Professor
- 1987 University of Chicago Pediatric Bone Marrow Transplantation Unit
- 1982 Istanbul University Istanbul Faculty of Medicine Pediatrics / Associate Professor
- 1981 University of Chicago Pediatric Hematology and Oncology / Specialist
- 1977 Istanbul University Istanbul Faculty of Medicine Pediatrics
- 1967 – 1973 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 1997 – 2013 Istanbul University Istanbul Faculty of Medicine, Department of Pediatrics, Hematology / Oncology / Faculty Member
- 2007 Acibadem Health Group
- 1994 – 1997 Istanbul University Istanbul Faculty of Medicine, Department of Pediatrics, Hematology and Oncology / Chairman
- 1985 – 1993 Istanbul University Oncology Institute Pediatric Oncology Division / Chairman
- 1987 – 1988 University of Chicago Pediatric Bone Marrow Transplantation Unit / Fellow
- 1982 – 1986 Istanbul University Istanbul Faculty of Medicine Department of Pediatrics Hematology and Oncology / Chairman
- 1979 – 1981 University of Chicago Division of Pediatric Hematology and Oncology / Fellow
- 1973 – 1979 Istanbul University Istanbul Faculty of Medicine, Department of Pediatrics / Specialist
Memberships
- International Society of Pediatric Oncology (SIOP)
- Children’s Oncology Group (COG)
- Turkish Pediatric Association
- American Society of Pediatric Hematologist, Oncology (ASPHO)
- Turkish Medical Association
- National Pediatric Institute
- Turkish Pediatric Oncology Group Association (TPOG)
- Turkish Pediatric Hemotology Society (TPHD)
- Turkish Hemotology Association (THD)
- European Hacmetology Association (EHA)
- International Society of Hemotology (ISH)
- American Society of Clinical Oncology (ASCO)
Publications
- Efficacy, Tolerability and Acceptability of Iron Hydroxide Polymaltose Complex Versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients With Iron Deficiency Anaemia.
Int J Pediatrics 2011;520-524 Yasa B, Agaoglu L, Unuvar E. - Respiratory syncytialvirus infection out break among pediatric patients withoncologic diseases and /or bmt
Pediatr Pulmonol 2010; 45(3): 307-11 Anak S, Atay D, Unuvar A, Garipardic M, Agaoglu L, Ozturk G, Karakas Z, Devecioglu O. - How to manage an unresectable or recurrent oblastoma.
Pediatr Blood Cancer. 2010; 55(2): 374-6. Saribeyoglu ET, Devecioglu O, Karakas Z, Anak S, Unuvar A, Agaoglu L, Celik A, Gulluoglu M, Bilgic B. - Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL.
Devecioglu O, Yildiz I, Ozbek U. / Dis Markers. 2010 Jan 1;28(6):353-60. Erbilgin Y, Sayitoglu M, Hatirnaz O, Dogru O, Akcay A, Tuysuz G, Celkan T, Aydogan G, Salcioglu Z, Timur C, Yuksel-Soycan L, Ure U, Anak S, Agaoglu L, - Efficacy and Safety of Deferasirox (Exjade®) in Patients with ß-Thalassemia Major Treated for up to 5 Years.
Clark J, Kattamis A. / ASH 51st Annual Meeting and Exposition, Blood 2009. Cappellini MD, Perrotta S, Agaoglu L, Aydinok Y, Capra M, Canatan D, Drelichman G, Kilinc Y, Magnano C, Porter JB, Piga A, Griffel L, Lagrone D, - Prospective evaluation of patient-reporte dout comes during treatment with defera sirox or defero xamine for iron overload in patients with beta-thalassemia.
Cario H, Zoumbos N, Vichinsky E, Opitz H, Ressayre-Djaffer C, Abetz L, Rofail D, Baladi JF. /ClinTher. 2007 May;29(5):909-17. Cappellini MD, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, LaiME,Mangiagli A, Strauss G, Girot R, Watman N, Ferster A, Loggetto S, Abish S, - Effects of iron deficiency anemia on cognitive function in children.
Arzneimittel-Forschung-Drug-Research 2007;57(6A):426-30. Agaoglu L, Torun O, Unuvar E, Sefil Y, Demir D. - A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.
DrelichmanG, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli / Blood. 2006 May 1;107(9):3455-62./Blood. 2006 May 1;107(9):3455-62. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y,Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, - The effect of iron deficiency anemia on the function of theimmune system.
Hematol J 5(7): 579-583, 2005 Ekiz C, Agaoglu L, Karakas Z, Gurel N, Yalcin I. - NAD(P)H: Quinone oxido reductase 1 null genotype is not associated with pediatric de novoa cute leukemia.
Pediatr Blood Cancer2004; 43: 568-70. Sirma S, Agaoglu L, Yildiz Y, Cayli D, Horgusluoglu E, Anak S, Yuksel L, Unuvar A, Celkan T, Apak H, Karakas Z, Devecioglu O, Ozbek U.
